Covered recipient · General Payments record
ALLA STEPANOVA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,683.02
- Reported across 245 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.77 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $124.99 | 1 |
| ABBVIE INC. | $72.89 | 3 |
| Lilly USA, LLC | $50.35 | 3 |
| Novo Nordisk AS | $34.72 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $28.35 | 1 |
| Acerta Pharma LLC | $20.17 | 1 |
| Amgen Inc. | $19.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.26 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108251269 | CMS |
| ABBVIE INC. | $30.50 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108251271 | CMS |
| ABBVIE INC. | $24.13 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108251273 | CMS |
| Amgen Inc. | $19.30 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692638 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.17 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104531144 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $28.35 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086304431 | CMS |
| Lilly USA, LLC | $16.34 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496034 | CMS |
| Lilly USA, LLC | $18.72 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135461078 | CMS |
| Lilly USA, LLC | $15.29 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135445079 | CMS |
| Novo Nordisk Inc | $18.47 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100381081 | CMS |
| Novo Nordisk Inc | $16.25 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100227480 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.99 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151207869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.